This article highlights how a 68-year-old man with Alzheimer's disease accessed expert U.S. care remotely through Medebound HEALTH after local treatments failed. Featuring a second opinion from a Cornell-affiliated neurologist and access to the FDA-approved drug Leqembi, the case underscores how families worldwide can now receive advanced Alzheimer’s care—without leaving home. The piece also reviews top U.S.